Skip to main content

Table 2 Patient characteristics part II:

From: Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy

Pat.No. Systemic therapy of primary disease Systemic therapy of secondary disease Recurrent tumour size (mm) Applicator size IORT (cm) Dose IORT (Gy) Treatment time IORT (Min)
1 GnRH Tamoxifen 12 3.5 20,0 18,60
2 6 × CMF AI 35 5.0 14,7 35,90
3 None GnRH 1 3.5 20,0 18,60
4 Tamoxifen AI 16 4.5 14,7 28,70
5 Tamoxifen AI 16 4.5 14,7 28,70
6 Tamoxifen AI 12 4.0 20,0 26,80
7 None AI 8 3.0 20,0 24,98
8 None Tamoxifen 7 4.0 20,0 26,80
9 6× CMF + Tam AI 15 4.0 20,0 26,80
10 3× CMF + Tam AI 18 4.0 20,0 26,80
11 None Tam 10 4.0 20,0 28,26
12 None AI 9 3.5 20,0 19,9
13 None none 11 5.0 20,0 49,5
14 None none 11 3.5 20,0 19,9
15 4× EC + Tam AI + GnRH 11 3.0 20,0 26,4
16 4× ABVD leftTamoxifen 11 2.5 20,0 19,2
17 none 4 × FEC 11 5.0 20 49.50
  1. GnRH = Gonadotropin Releasing-Hormone Analoga, Tam = Tamoxifen, CMF = Cyclophosphamide (600 mg/m2)/Methotrexate (40 mg/m2)/5-Fluorouracil (600 mg/m2)
  2. EC = Epirubicin (90 mg/m2)/Cyclophosphamide (600 mg/m2), AI = Aromatase inhibitors
  3. ABVD = Adriamycin, Bleomycin, Vinblastin, DTIC